98%
921
2 minutes
20
Rationale: Influenza is an infection caused by the influenza virus, and its symptoms are mostly mild and self-limiting. However, influenza can cause severe or fatal complications in high-risk patients. Although tracheobronchitis is one of the common complications of influenza, necrotizing tracheobronchitis is very rare. Herein, we describe a case of necrotizing tracheobronchitis causing airway obstruction complicated by pandemic 2009 H1N1 influenza.
Patient Concerns: A 60-year-old man presented with fever and dyspnea. On arrival at the emergency room (ER), the patient received oxygen 4 L/minute via a nasal prolong owing to mild hypoxemia. And invasive mechanical ventilation was needed 5 hours after arrival at the ER due to progressive hypoxemia.
Diagnoses: Fiberoptic bronchoscopy was performed owing to bloody secretion in the endotracheal tube and revealed diffuse tracheobronchitis with necrotic and hemorrhagic materials obstructing the trachea and bronchus. The pandemic 2009 H1N1 influenza virus was detected from the bronchial washing sample; no other microorganism was detected.
Intervention: He received peramivir plus oseltamivir and broad-spectrum antibiotics.
Outcomes: The bloody secretion continued. He developed cardiac arrest due to airway obstruction on the 6th day of admission. After cardiac arrest, his condition progressed to multi-organ failure, and the patient died on the 10th day of admission.
Lessons: We suggest that necrotizing tracheobronchitis be considered in patients with influenza who present with unexplained hypoxemia.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946318 | PMC |
http://dx.doi.org/10.1097/MD.0000000000018647 | DOI Listing |
Am J Case Rep
April 2025
Department of Intensive Care Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, Netherlands.
BACKGROUND Aspergillus tracheobronchitis is a rare, high mortality condition typically seen in immunocompromised patients. Although commonly associated with classic immunocompromising conditions, such as immunosuppression due to chemotherapy or corticosteroids, or neutropenia, it can also develop in patients with sepsis-induced immunoparalysis, which is the term used to describe an immunocompromised state that results of imbalances in the inflammatory response in sepsis. Immunostimulatory therapy with interferon (IFN)-γ can be a viable treatment option in these cases.
View Article and Find Full Text PDFZhonghua Jie He He Hu Xi Za Zhi
April 2025
Department of Respiratory and Critical Care Medicine, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou 253000, China.
This study presented a rare case of secondary () infection following influenza B virus infection, resulting in diffuse airway injury and hemorrhagic pneumonia. The patient initially underwent bronchial artery embolization (BAE) due to persistent hemoptysis refractory to conventional hemostatic therapy. Although the hemoptysis was resolved postoperatively, severe hypoxemia persisted.
View Article and Find Full Text PDFBraz J Infect Dis
March 2025
Universidade Federal de São Paulo, Divisão de Doenças Infecciosas Pediátricas, São Paulo, SP, Brazil; Federal Universidade de São Paulo, Instituto de Oncologia Pediátrica, Grupo de Apoio ao Adolescente e Criança com Câncer, São Paulo, SP, Brazil. Electronic address:
Background: Ceftazidime-Avibactam (CAZ-AVI) plays a key role in the treatment of Multidrug Resistant Gram-Negative Bacilli (MDR-GNB) infections. In pediatrics, CAZ-AVI is clinically approved for treatment of urinary tract or intra-abdominal infection. However, there is limited data available about its use in children with cancer who have complicated infections caused by MDR-GNB.
View Article and Find Full Text PDFEur J Case Rep Intern Med
January 2025
Pulmonary Medicine, Adventist Health Castle Medical Center, Kailua, USA.
Introduction: Aspergillus is a ubiquitous fungus causing various pulmonary diseases depending on the host's immune status. Aspergillus tracheobronchitis, a rare form of invasive aspergillosis, primarily affects severely immunocompromised or critically ill patients. We present the first known case of Aspergillus tracheobronchitis complicated by tracheal perforation and subcutaneous emphysema successfully treated with conservative endotracheal tube manipulation.
View Article and Find Full Text PDFSci Rep
September 2024
Department of Pediatric Intensive Care Unit (PICU), Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310052, China.